Your browser doesn't support javascript.
loading
Vascular effects of serelaxin in patients with stable coronary artery disease: a randomized placebo-controlled trial.
Corcoran, David; Radjenovic, Aleksandra; Mordi, Ify R; Nazir, Sheraz A; Wilson, Simon J; Hinder, Markus; Yates, Denise P; Machineni, Surendra; Alcantara, Jose; Prescott, Margaret F; Gugliotta, Barbara; Pang, Yinuo; Tzemos, Niko; Semple, Scott I; Newby, David E; McCann, Gerry P; Squire, Iain; Berry, Colin.
Afiliación
  • Corcoran D; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • Radjenovic A; Golden Jubilee National Hospital, Glasgow, UK.
  • Mordi IR; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • Nazir SA; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • Wilson SJ; Golden Jubilee National Hospital, Glasgow, UK.
  • Hinder M; Department of Cardiovascular Sciences, University of Leicester and NIHR Leicester Biomedical Research Centre, Leicester, UK.
  • Yates DP; British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
  • Machineni S; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Alcantara J; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Prescott MF; Novartis Healthcare Private Limited, Hyderabad, India.
  • Gugliotta B; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Pang Y; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Tzemos N; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Semple SI; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Newby DE; London Health Science Centre, University of Western Ontario, London, Ontario, Canada.
  • McCann GP; British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
  • Squire I; British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
  • Berry C; Department of Cardiovascular Sciences, University of Leicester and NIHR Leicester Biomedical Research Centre, Leicester, UK.
Cardiovasc Res ; 117(1): 320-329, 2021 01 01.
Article en En | MEDLINE | ID: mdl-32065620
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Relaxina / Vasodilatación / Vasodilatadores / Enfermedad de la Arteria Coronaria / Circulación Coronaria / Rigidez Vascular / Presión Arterial Tipo de estudio: Clinical_trials / Observational_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Cardiovasc Res Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Relaxina / Vasodilatación / Vasodilatadores / Enfermedad de la Arteria Coronaria / Circulación Coronaria / Rigidez Vascular / Presión Arterial Tipo de estudio: Clinical_trials / Observational_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Cardiovasc Res Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido